市场快照
| Study Period: | 2018 - 2026 |
| Base Year: | 2021 |
| Fastest Growing Market: | Asia Pacific |
| Largest Market: | North America |
| CAGR: | >10.5 % |
|
Need a report that reflects how COVID-19 has impacted this market and its growth?
市场概况
在预测期内，研究的分子质量控制市场预计将以近 10.5% 的复合年增长率增长。导致市场增长的主要因素是传染病、艾滋病毒、癌症的全球流行率上升，这需要新的诊断方法来进行有效的治疗和质量控制以监测其性能。例如，根据 2019 年发布的联合国艾滋病毒和艾滋病联合规划署 (UNAIDS) 报告，全球有 2450 万艾滋病毒感染者正在接受抗逆转录病毒治疗。此外，政府更多地参与控制传染病的爆发，以及对质量评估支持以及即时诊断系统的需求增加，预计将有助于预测期内全球市场的增长
报告范围
分子质量控制用于评估分子测试的性能，例如用于病毒载量测定的体外核酸测试程序、病原体检测、白细胞减少的单采血小板 (LRAP) 单位、医疗保健相关感染 (HAI)，如肺炎、尿路感染和更多。这些产品主要专注于缺陷检测、质量控制和验证面板，以支持临床和研究实验室、血液诊断中心和 IVD 制造商实施和监测检测试剂盒批次的性能。
| By Product Type | |
| Independent Control | |
| Instrument Specific-Control |
| By Application | |
| Oncology | |
| Genetic Testing | |
| Infectious Diseases | |
| Others |
| By End-users | |
| Hospitals | |
| Clinical Laboratories | |
| IVD Manufacturers & CROs | |
| Others |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
主要市场趋势
预计独立控制将在分子质量控制市场中占有最大的市场份额
独立控制预计将在分子质量控制市场占据最大的市场份额，因为它们在短时间内对测试系统或方法性能测试结果进行高度精确、公正和独立的评估，并且由于它们是独立制造的，因此具有最高的灵敏度仪器、试剂和校准品。此外，由于这些产品的广泛应用以及降低运营成本等优势，第三方独立质量控制机构对这些产品的采用率急剧上升，预计也将推动独立控制机构的使用，从而推动市场发展。
基于该应用程序，由于全球癌症患病率的上升、对癌症生物标志物的研究增加、先进的诊断基础设施以及对个性化医疗的日益关注，肿瘤学领域的市场收入最高。另一方面，由于基因检测在各种遗传性疾病的治疗和基因诊断中的应用增加，以及确定驱动可能推动该细分市场的血统，因此预计基因检测在预测期内的复合年增长率最高。预测期内的全球市场。
To understand key trends, Download Sample Report
北美在市场上占主导地位，预计在预测期内也会如此。
在整个预测期内，预计北美将主导整个分子质量控制市场。先进基础设施的高采用率、诊断中心数量的增加和经认可的临床实验室是估计推动该地区市场的因素。在北美，美国拥有最大的市场份额，原因是 增加患者库。例如，根据美国卫生与公众服务部 2020 年发布的报告，2018 年美国约有 37,832 人被诊断出感染了 HIV，而美国和 6 个依赖地区每年仍有 38,000 例新的 HIV 感染，导致快速各种传染病的传播，如脑膜炎、尿路感染，推动市场在预测期内贡献了其在全球市场收入中的突出份额
To understand geography trends, Download Sample Report
竞争格局
分子质量控制市场竞争适度，由几个主要参与者组成。一些公司正在通过收购和合并等各种策略扩大其市场地位，而另一些公司则正在开发新的治疗方法并推出新产品以保持其市场份额。例如，2019 年 4 月，布鲁克通过为其 MALDI Biotyper、IR Biotyper 和 Fluorocycler XT 产品线引入新的检测、软件和库扩展，扩大了其在传染病微生物鉴定、感染控制和分子诊断方面的产品组合。对市场产生积极影响。目前主导市场的一些公司是 Bio-Rad Laboratories Inc F. Hoffmann-La Roche AG、SeraCare Life Sciences Inc、bioMerieux Inc、
Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Increased Demand for Advanced Diagnostics for Sensitve Reports and Accurate Diagnosis
-
4.2.2 Rise Global Incidence of Infectious Diseases, Cancers and Genetic Disorders
-
4.2.3 Rise in the Volume of Accredited Clinical Laboratories and Adoption of Third-Party Quality Controls
-
-
4.3 Market Restraints
-
4.3.1 Complex Regulatory Framework by Authorities Delaying Approvals
-
4.3.2 Unfavorable Reimbursement Poilicies for Molecular Tests
-
4.3.3 Additional Costs Involved in Quality Control testing Resulting in Budget Constraints for Healthcare Providers
-
4.3.4 Lack of Stringent Regulations for Clinical Laboratory Accreditation in Several Emerging Economies
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Product Type
-
5.1.1 Independent Control
-
5.1.2 Instrument Specific-Control
-
-
5.2 By Application
-
5.2.1 Oncology
-
5.2.2 Genetic Testing
-
5.2.3 Infectious Diseases
-
5.2.4 Others
-
-
5.3 By End-users
-
5.3.1 Hospitals
-
5.3.2 Clinical Laboratories
-
5.3.3 IVD Manufacturers & CROs
-
5.3.4 Others
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia-Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle-East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle-East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Abbott Laboratories
-
6.1.2 Bio-Rad Laboratories Inc
-
6.1.3 F. Hoffmann-La Roche AG
-
6.1.4 Microbiologics Inc
-
6.1.5 Thermo Fisher Scientific
-
6.1.6 SeraCare Life Sciences Inc
-
6.1.7 ZeptoMetrix Corporation
-
6.1.8 Quidel Corporation
-
6.1.9 Qnostics Ltd
-
6.1.10 bioMerieux Inc
-
*List Not Exhaustive -
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Molecular Quality Controls Market market is studied from 2018 - 2026.
What is the growth rate of Molecular Quality Controls Market?
The Molecular Quality Controls Market is growing at a CAGR of >10.5% over the next 5 years.
Which region has highest growth rate in Molecular Quality Controls Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Molecular Quality Controls Market?
North America holds highest share in 2021.
Who are the key players in Molecular Quality Controls Market?
Bio-Rad Laboratories Inc, bioMerieux Inc, F. Hoffmann-La Roche AG, SeraCare Life Sciences Inc, ZeptoMetrix Corporation are the major companies operating in Molecular Quality Controls Market.
